|
Volumn 67, Issue 12, 2008, Pages 1787-1790
|
Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-tumour necrosis factor α
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DISEASE MODIFYING ANTIRHEUMATIC DRUG;
GLUCOCORTICOID;
INFLIXIMAB;
METHYLPREDNISOLONE;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
ADULT;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CONTROLLED STUDY;
DOPPLER ECHOGRAPHY;
DRUG EFFICACY;
DRUG SAFETY;
ERYTHROCYTE SEDIMENTATION RATE;
FEMALE;
HUMAN;
LETTER;
MALE;
MONARTHRITIS;
PRIORITY JOURNAL;
PSORIATIC ARTHRITIS;
RHEUMATOID ARTHRITIS;
SCORING SYSTEM;
VISUAL ANALOG SCALE;
ADULT;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, PSORIATIC;
ARTHRITIS, RHEUMATOID;
DRUG RESISTANCE;
DRUG THERAPY, COMBINATION;
FEMALE;
GLUCOCORTICOIDS;
HUMANS;
INJECTIONS, INTRA-ARTICULAR;
MALE;
MIDDLE AGED;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 56749178275
PISSN: 00034967
EISSN: 14682060
Source Type: Journal
DOI: 10.1136/ard.2008.091900 Document Type: Letter |
Times cited : (33)
|
References (9)
|